Prognosis Prediction and Surgical Benefit Subgroup Analysis in Anal Squamous Cell Carcinoma Patients Undergoing Concurrent Chemoradiotherapy
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new nomogram accurately predicts survival for anal squamous cell carcinoma (ASCC) patients treated with chemoradiotherapy. It also identifies male patients who may benefit from surgery, aiding personalized treatment decisions.
Area Of Science
- Oncology
- Medical Statistics
Background
- Anal squamous cell carcinoma (ASCC) is a rare malignancy.
- Chemoradiotherapy is a standard treatment for ASCC.
- Predicting prognosis and identifying optimal treatment strategies remain challenging.
Purpose Of The Study
- To develop and validate a nomogram for predicting overall survival in ASCC patients.
- To identify ASCC patients who may benefit from surgical intervention.
- To compare the nomogram's performance with the AJCC staging system.
Main Methods
- Retrospective analysis of 4697 ASCC patients from the SEER database.
- Development of a nomogram using LASSO and Cox regression.
- Internal and external validation of the nomogram's discriminatory and calibration abilities.
- Decision curve analysis and subgroup analysis to assess clinical utility and identify surgical candidates.
Main Results
- Age, sex, tumor size, and AJCC stage were identified as independent prognostic factors.
- The nomogram demonstrated strong predictive accuracy and outperformed the AJCC staging system.
- Risk stratification revealed significant survival differences among patient subgroups.
- Subgroup analysis indicated potential benefit from surgery in male ASCC patients.
Conclusions
- The developed nomogram is a valuable tool for predicting long-term prognosis in ASCC patients.
- The nomogram aids in personalized treatment decisions, particularly regarding surgical intervention for specific patient groups.
- Further research may explore the role of surgery in male ASCC patients.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...